NEWS
Sheffield Pharmaceuticals is pleased to announce that we have successfully concluded our recent FDA audit, performed at our manufacturing facility Sept 10th to Sept. 16th. Sheffield received no 483 observations, therefore there are no GMP corrective actions required
Sheffield proudly stands behind the quality of our validated products. Our manufacturing facility is cGMP compliant and supported with strong quality systems and our dedication to continuous improvement.
At Sheffield Pharmaceuticals we are continuously improving our facilities and manufacturing processes to exceed the expectations of our customers. We are strategically positioned to provide our customers with products that deliver and meet FDA quality standards. We look forward to confidently serving our customers where we operate as a integral supply partner.
